Cyclin D1 Antikörper (C-Term)
Kurzübersicht für Cyclin D1 Antikörper (C-Term) (ABIN927860)
Target
Alle Cyclin D1 (CCND1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - C-Term
 - 
                                            
Kreuzreaktivität
 - Maus
 - 
                                            
Aufreinigung
 - Purified
 - 
                                            
Immunogen
 - Ccnd1 antibody was raised in rabbit using the C terminal of Ccnd1 as the immunogen
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Konzentration
 - Lot specific
 - 
                                            
Buffer
 - Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
 - 
                                            
Handhabung
 - Avoid repeated freeze/thaw cycles.
 - 
                                            
Lagerung
 - 4 °C/-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
 - 
                                            
 - 
    
- Cyclin D1 (CCND1)
 - 
                                            
Andere Bezeichnung
 - Ccnd1
 - 
                                            
Hintergrund
 - Ccnd1 is essential for the control of the cell cycle at the G1/S (start) transition. Synonyms: Polyclonal Ccnd1 antibody, Anti-Ccnd1 antibody, cyclin D1 antibody, AI327039 antibody, Cyl-1 antibody, PRAD1 antibody, bcl-1 antibody, cD1 antibody.
 - 
                                            
Pathways
 - PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
 
Target
 -